Pancreas survival in simultaneous pancreas-kidney and pancreas-after-kidney transplantations: A five-year follow-up report

2012 ◽  
Vol 17 (3) ◽  
pp. 14-19 ◽  
Author(s):  
Alihan Gurkan
2009 ◽  
Vol 9 (2) ◽  
pp. 355-366 ◽  
Author(s):  
H. P. Tan ◽  
J. Donaldson ◽  
A. Basu ◽  
M. Unruh ◽  
P. Randhawa ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Philip Zeuschner ◽  
Michael Stöckle ◽  
Robert Peters ◽  
Kurt Miller ◽  
Lutz Liefeldt ◽  
...  

<b><i>Objectives:</i></b> Right laparoscopic donor nephrectomy (RLDN) is no longer regarded inferior to left LDN (LLDN). However, this knowledge is based on many studies suffering from inherent learning curves, center-specific imbalances, and different laparoscopic techniques. <b><i>Methods:</i></b> Pure LDNs at a high-volume referral center from 2011 to 2016 were retrospectively analyzed. Patient, graft characteristics, outcomes of LDNs, and corresponding open kidney transplantations were compared between LLDN and RLDN including a follow-up. <b><i>Results:</i></b> 160 (78.4%) LLDNs and 44 (21.6%) RLDNs only differed regarding graft characteristics, as more right grafts had multiple veins (34.1 vs. 6.9%, <i>p</i> &#x3c; 0.001) and worse scintigraphic function (44 vs. 51%, <i>p</i> &#x3c; 0.001). RLDNs were shorter (201 vs. 220 min, <i>p</i> = 0.032) with longer warm ischemia time (165 vs. 140 s, <i>p</i> &#x3c; 0.001), but left grafts were transplanted faster (160 vs. 171 min, <i>p</i> = 0.048). Recipients of right kidneys had more postoperative complications (grade 3: 25.6 vs. 11.3%, <i>p</i> = 0.020). At a follow-up of 45 (range 6–79) months, neither the kidney function, nor death-censored graft (5-year: LLDN 89 vs. 92%, <i>p</i> = 0.969) and patient survival (5-year: LLDN 95 vs. 98%, <i>p</i> = 0.747) differed. <b><i>Conclusions:</i></b> Pure LLDN and RLDN can have different outcomes at high-volume centers, especially higher complications for recipients of right grafts. However, long-term function and graft survival are the same irrespective of the chosen side.


2016 ◽  
Vol 16 (2) ◽  
pp. 8-11
Author(s):  
Janis Jushinskis ◽  
Vadims Suhorukovs ◽  
Aleksandrs Malcevs ◽  
Ieva Ziedina ◽  
Rafails Rozentals

SummaryIntroduction.During the previous years the number of organ transplantations from elderly donors increased, and lack of young donors leads to necessity to allocate organs from elderly into young recipients.Aim of the Study.Was to analyse results of “old-to-young” allocation.Material and methods.This retrospective study analysed results of all consecutive deceased donor kidney transplantations (DDKT) performed in one transplant centre during the period from 01.01.2004 till 31.12.2007. Patients were selected based on availability of 5-year follow-up and age < 50 years (158 DDKT). Patients were divided into 2 groups according to donor age: age-mismatched group (donor age was > 55 years and at the same time > 15 years older than recipient; n=8, male/female=2/6, age 39,4 + 4,8 years, donor age 59,4 + 2,4 years), and age-matched group (n=150, male/female=88/62, age 36,0 + 11,0 years, donor age 37,3 + 12,0 years). Groups were compared for clinical and demographical features and posttransplant outcomes (delayed graft function, s-creatinin levels at discharge and after 5 years, acute rejection rate, graft and patient 5-year survival).Results.Comparison of demographical and clinical features revealed only relatively higher BMI in elderly donors (p=0.081) and higher frequency of age-mismatched allocation into female recipients (p=0.066). Early and late post-transplant outcomes showed no significant difference between groups, with similar 5-year graft and patient survival (p=NS for all compared factors).Conclusion.Results showed good kidney allograft function even in cases of age-mismatched allocation, which is significant opportunity in current situation with increasing age of deceased donors.


2004 ◽  
Vol 78 (12) ◽  
pp. 1802-1808 ◽  
Author(s):  
Oliver Drognitz ◽  
Stefan Benz ◽  
Frank Pfeffer ◽  
Christoph Fischer ◽  
Frank Makowiec ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Madelon van Agteren ◽  
Willem Weimar ◽  
Annelies E. de Weerd ◽  
Peter A. W. te Boekhorst ◽  
Jan N. M. Ijzermans ◽  
...  

This study describes the single center experience and long-term results of ABOi kidney transplantation using a pretransplantation protocol involving immunoadsorption combined with rituximab, intravenous immunoglobulins, and triple immune suppression. Fifty patients received an ABOi kidney transplant in the period from 2006 to 2012 with a follow-up of at least one year. Eleven antibody mediated rejections were noted of which 5 were mixed antibody and cellular mediated rejections. Nine cellular mediated rejections were recorded. Two grafts were lost due to rejection in the first year. One-year graft survival of the ABOi grafts was comparable to 100 matched ABO compatible renal grafts, 96% versus 99%. At 5-year follow-up, the graft survival was 90% in the ABOi versus 97% in the control group. Posttransplantation immunoadsorption was not an essential part of the protocol and no association was found between antibody titers and subsequent graft rejection. Steroids could be withdrawn safely 3 months after transplantation. Adverse events specifically related to the ABOi protocol were not observed. The currently used ABOi protocol shows good short and midterm results despite a high rate of antibody mediated rejections in the first years after the start of the program.


2008 ◽  
Vol 86 (Supplement) ◽  
pp. 277
Author(s):  
H Tan ◽  
J Donaldson ◽  
A Basu ◽  
M Unruh ◽  
P Randhawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document